Victoria L Banks (Victoria Banks)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Chronic Obstructive Pulmonary Disease

Metastatic Colorectal Cancer

Clinical Practice

Top Venues

International journal of chronic obstructive pulmonary disease

Future oncology (London, England)

Respiratory research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 24 (1) (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Maria Duarte, Afisi S Ismaila
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Dual Therapy in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 17 (2022)
David M G Halpin, Kieran J Rothnie, Victoria L Banks, Alexandrosz Czira, Chris Compton, Robert P Wood, Theo Tritton, Olivia Massey, Rosie A C Wild, Neil G Snowise, Kirill Nikitin, Raj Sharma, Afisi S Ismaila, Claus F Vogelmeier
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International journal of chronic obstructive pulmonary disease 17 (2022)
George Kafatos, Victoria L Banks, Peter Burdon, David Neasham, Kimberly A Lowe, Caroline Anger, Fil Manuguid, Jörg Trojan
Impact of biomarkers and primary tumor location on the metastatic colorectal cancer first-line treatment landscape in five European countries. Future oncology (London, England) 17 (12) (2021)
George Kafatos, Victoria L Banks, Peter Burdon, David Neasham, Caroline Anger, Fil Manuguid, Kimberly A Lowe, Patrick Cheung, Gilles Manceau, Joannes Han van Krieken
Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database. Future oncology (London, England) 17 (12) (2021)
Karly S Louie, Victoria L Banks, Florian Scholz, Hartmut Richter, Katarina Öhrling, Peter Mohr, Sebastian Haferkamp
Real-world use of talimogene laherparepvec in Germany: a retrospective observational study using a prescription database. Future oncology (London, England) 16 (8) (2020)